This funding opportunity supports research generating real-world evidence on clinical outcomes of ATM-AVI treatment in adult patients infected with Stenotrophomonas maltophilia. The grant aims to advance understanding of treatment effectiveness in this infectious disease area through independent health initiatives.
Eligibility criteria are not specified for this funding opportunity.
